Nice | Rivaroxaban for treating PE and preventing recurrent embolism

2nd August 2013 by Louise Hudman

Another guideline about Rivaroxaban. Guidance was published in 2012 advising that Rivaroxaban could be used in the treatment of DVT. At that point, there was no guidance about its use in PEs. Since then a study has shown that it is as effective as Warfarin in the treatment of PE. Therefore this new guideline advises that Rivaroxaban can be used in the treatment of PE and for the prevention of recurrent PE and DVT.

Its main advantage is that it does not need monitoring. Its main disadvantage is that its effects are not easily reversible. It is also expensive.

 

Read more

No credit card details needed – it takes two minutes.

Join free trial

Login

Already a member? Login to view this content.

Login

"I have been a member of the NASGP for the past nine years and have found the advice and support offered invaluable. NASGP passionately champions for safe and fair working conditions for locums, which is crucial in an age of increasing medical litigation.

LocumDeck is a must for every locum who just wants to get on with the job that they were trained to do."

Dr Fiona Munro, GP

Dr Fiona Munro, GP

See the full list of features within our NASGP membership plans

Membership